Avidity Biosciences Inc. (RNA)
27.82
0.77 (2.85%)
At close: Jan 15, 2025, 1:37 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -212.22M | -174.00M | -118.01M | -44.35M | -24.73M | -11.22M |
| Depreciation & Amortization | 2.10M | 1.39M | 639.00K | 373.00K | 348.00K | 383.00K |
| Stock-Based Compensation | 38.22M | 27.14M | 17.06M | 4.31M | 406.00K | 60.00K |
| Other Working Capital | 59.36M | -8.50M | -705.00K | -3.42M | 18.67M | 671.00K |
| Other Non-Cash Items | -8.30M | -615.00K | 163.00K | 139.00K | 7.35M | 447.00K |
| Deferred Income Tax | n/a | n/a | n/a | 84.00K | n/a | n/a |
| Change in Working Capital | 61.13M | 9.82M | 5.34M | 2.33M | 19.12M | 671.00K |
| Operating Cash Flow | -119.06M | -136.27M | -94.81M | -37.12M | 2.49M | -9.65M |
| Capital Expenditures | -4.23M | -2.82M | -3.74M | -1.09M | -235.00K | -49.00K |
| Acquisitions | n/a | 187.13M | 82.52M | n/a | n/a | n/a |
| Purchase of Investments | -461.00M | -355.84M | -85.36M | -6.69M | n/a | n/a |
| Sales Maturities Of Investments | 335.16M | 168.71M | 6.58M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -187.13M | -82.52M | -6.69M | n/a | n/a |
| Investing Cash Flow | -130.07M | -189.96M | -82.52M | -7.79M | -235.00K | -49.00K |
| Debt Repayment | n/a | n/a | n/a | -4.68M | 16.65M | 4.98M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | -106.00K | n/a |
| Other Financial Acitivies | 33.32M | 1.39M | 1.64M | 2.67M | 72.69M | 162.00K |
| Financial Cash Flow | 93.86M | 346.17M | 176.32M | 272.04M | 89.23M | 5.14M |
| Net Cash Flow | -155.27M | 19.95M | -1.01M | 227.13M | 91.49M | -4.56M |
| Free Cash Flow | -123.29M | -139.09M | -98.55M | -38.21M | 2.25M | -9.70M |